{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:40:42Z","timestamp":1683074442130},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf01516935","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T22:49:05Z","timestamp":1113864545000},"page":"1-6","source":"Crossref","is-referenced-by-count":5,"title":["Tumoricidal effect of human macrophage-colony-stimulating factor against human-ovarian-carcinoma-bearing athymic mice and its therapeutic effect when combined with cisplatin"],"prefix":"10.1007","volume":"37","author":[{"given":"Toshio","family":"Adachi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Mano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Ino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomitsu","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Nawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setsuko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Tomoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/1097-0142(19910215)67:4<990::AID-CNCR2820670422>3.0.CO;2-8","volume":"67","author":"GB Baiocchi","year":"1991","unstructured":"Baiocchi GB, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R (1991) Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer 67: 990","journal-title":"Cancer"},{"key":"CR2","first-page":"157","volume":"33","author":"S Chattopadhyay","year":"1985","unstructured":"Chattopadhyay S, Bhattacharyya S, Chakrabarty NG (1985) Tumor associated macrophage mediated lysis of autologous tumor cells. Neoplasma 33: 157","journal-title":"Neoplasma"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ijc.2910440508","volume":"44","author":"A Erroi","year":"1989","unstructured":"Erroi A, Sinori M, Chiaffarino F, Zhen-Guo C, Mengozzi M, Mantovani A (1989) IL-1 and IL-6 release by tumor associated macrophages from human ovarian carcinoma. Int J Cancer 44: 795","journal-title":"Int J Cancer"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jlb.35.6.561","volume":"35","author":"R Evans","year":"1984","unstructured":"Evans R, Cullen RT (1984) In situ proliferation of intratumor macrophages. J Leukocyte Biol 35: 561","journal-title":"J Leukocyte Biol"},{"key":"CR5","first-page":"821","volume":"10","author":"HG Fehr","year":"1990","unstructured":"Fehr HG, Fan S, Lotzerich H, Appell HJ (1990) Cytokine stimulation of antibody dependent cellular cytotoxicity (ADCC) enhances cytolytic but not binding capacity of peritoneal macrophages. Anticancer Res 10: 821","journal-title":"Anticancer Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4049\/jimmunol.138.2.635","volume":"138","author":"R Feinman","year":"1987","unstructured":"Feinman R, Henriksen-DeStefano D, Tsujimoto M, Vilcek J (1987) Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J Immunol 138: 635","journal-title":"J Immunol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0378-4347(00)82037-X","volume":"344","author":"K Hatake","year":"1985","unstructured":"Hatake K, Motoyoshi K, Ishizuka Y, Takaku F, Miura Y (1985) Purification of human urinary colony-stimulating factor by high performance liquid chromatography. J Chromatogr 344: 339","journal-title":"J Chromatogr"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0006-291X(88)80060-3","volume":"157","author":"J Horiguchi","year":"1988","unstructured":"Horiguchi J, Sherman ML, Sampson-Johanners A, Weber BL, Kufe DW (1988) CSF-i and c-fms gene expression in human carcinoma cell lines. Biochem Biophys Res Commun 157: 395","journal-title":"Biochem Biophys Res Commun"},{"key":"CR9","first-page":"69","volume":"8","author":"DA Hume","year":"1989","unstructured":"Hume DA, Donahue RE, Fidler IJ (1989) The therapeutic effect of human recombinant macrophage colony stimulating factor (CSF-1) in experimental murine metastatic melanoma. Lymphokine Res 8: 69","journal-title":"Lymphokine Res"},{"issue":"Suppl 1","key":"CR10","first-page":"140","volume":"15","author":"BM Kacinski","year":"1988","unstructured":"Kacinski BM, Bloodgood RS, Carter D, Yang-Feng T (1988) M-CSF (CSF-1), its receptor thefms protein, and other lymphohematopoietic factor and receptors involved in macrophage activation (IL-3, G-IFN, GM-CSF) play important roles in producing the proliferative and invasive characteristics of human ovarian endometrial and other (breast, lung) adenocarcinomas in vivo and in vitro. Int J Radiat Oncol Biol Phys [Suppl 1] 15: 140","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0360-3016(89)90383-0","volume":"17","author":"BM Kacinski","year":"1989","unstructured":"Kacinski BM, Stanley ER, Carter D, Chambers JT, Chambers SK, Kohorn EL, Schwartz PE (1989) Circulating level of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasmas. Int J Radiat Oncol Biol Phys 17: 159","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ijc.2910440323","volume":"44","author":"R Keller","year":"1989","unstructured":"Keller R, Keist R, Schwendener RA (1989) Discrepancy in the abilities of lymphokines and bacteria to mediate tumor protection in vivo and\/or tumoricidal activity macrophages in vitro. Int J Cancer 44: 512","journal-title":"Int J Cancer"},{"key":"CR13","first-page":"592","volume":"47","author":"Y Kikuchi","year":"1987","unstructured":"Kikuchi Y, Kizawa I, Oomori K, Miyauchi M, Kita T, Sugita M, Tenjin Y, Kato K (1987) Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation. Cancer Res 47: 592","journal-title":"Cancer Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jlb.41.3.205","volume":"41","author":"KH Mahoney","year":"1987","unstructured":"Mahoney KH, Heppner GH (1987) FACS analysis of tumor associated macrophage replication: differences between metastatic and non-metastatic murine mammary tumors. J Leukocyte Biol 41: 205","journal-title":"J Leukocyte Biol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/jnci\/64.6.1307","volume":"64","author":"A Mantovani","year":"1980","unstructured":"Mantovani A, Polentarutti N, Peri G, Shavit ZB, Vecchi A, Bolis G, Mangioni C (1980) Cytotoxicity on tumor cells of peripheral blood monocytes and tumor associated macrophages in patients with ascites ovarian tumor. JNCI 64: 1307","journal-title":"JNCI"},{"key":"CR16","first-page":"27","volume":"865","author":"WH McBride","year":"1986","unstructured":"McBride WH (1986) Phenotype and function of intratumoral macrophages. Biochim Biophys Acta 865: 27","journal-title":"Biochim Biophys Acta"},{"key":"CR17","first-page":"1069","volume":"47","author":"L Milas","year":"1987","unstructured":"Milas L, Wike J, Hunter N, Volpe J, Basic I (1987) Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability. Cancer Res 47: 1069","journal-title":"Cancer Res"},{"key":"CR18","first-page":"161","volume-title":"Hematopoietic growth factors in clinical application","author":"K Motoyoshi","year":"1991","unstructured":"Motoyoshi K, Takaku F (1991) Human monocytic colony-stimulating factor (hM-CSF), phase I\/II clinical studies: In: Hematopoietic growth factors in clinical application. Dekker, New York, p 161"},{"key":"CR19","first-page":"72","volume":"27","author":"K Motoyoshi","year":"1992","unstructured":"Motoyoshi K, Takaku F (1992) Clinical application of human macrophage colony-stimulating factor in cancer therapy. J Jpn Soc Cancer Ther 27: 72","journal-title":"J Jpn Soc Cancer Ther"},{"key":"CR20","first-page":"301","volume-title":"Monokines and other non-lymphocytic cytokines","author":"K Motoyoshi","year":"1988","unstructured":"Motoyoshi K, Takaku F, Hatake K, Yanai N, Kawashima T, Saito M, Miura Y, Wong GG, Fujisawa M, Yuo A, Okabe T, Takaku F (1988) Recombinant human monocyte colony stimulating factor stimulates both immature and mature cells of human monocyte lineage. In: Monokines and other non-lymphocytic cytokines. Liss, New York, p 301"},{"key":"CR21","first-page":"68","volume":"17","author":"K Motoyoshi","year":"1989","unstructured":"Motoyoshi K, Yoshida K, Hatake K, Saito M, Miura Y, Yanai N, Yamada K, Yamada M, Kawashima T, Wong GG, Temple PA, Leary AC, Witek-Giannoti JS, Fuzisawa M, Yuo A Okabe T, Takaku F (1989) Recombinant and native human urinary colonystimulating factor directly augments granulocytic and granulocyte-macrophage colony-stimulating factor production from human peripheral blood monocytes. Exp Haematol 17: 68","journal-title":"Exp Haematol"},{"key":"CR22","first-page":"253","volume-title":"The biology of the interferon system","author":"K Motoyoshi","year":"1989","unstructured":"Motoyoshi K, Yoshida K, Yanai N, Takaku F (1989) Role of human monocytic colony-stimulating factor in hematopoiesis. In: The biology of the interferon system. Kodansha Scientific, Tokyo, p 253"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0008-8749(89)90234-7","volume":"119","author":"RA Mufson","year":"1989","unstructured":"Mufson RA, Aghajanian J, Wong G, Woodhouse C, Morgan AC (1989) Macrophage colony stimulating factor enhances monocyte and macrophage antibody dependent cell mediated cytotoxicity. Cell Immunol 119: 182","journal-title":"Cell Immunol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00048093","volume":"4","author":"SJ Normann","year":"1985","unstructured":"Normann SJ (1985) Macrophage infiltration and tumor progression. Cancer Metastasis Rev 4: 277","journal-title":"Cancer Metastasis Rev"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0192-0561(91)90098-R","volume":"13","author":"A Suresh","year":"1991","unstructured":"Suresh A, Sodhi A, Singh SM, Basu S (1991) In vitro activation of murine bone marrow-derived macrophages with cisplatin and mitomycin-C. Int J Immunopharmacol 13: 189","journal-title":"Int J Immunopharmacol"},{"key":"CR26","first-page":"5913","volume":"49","author":"S Suzu","year":"1989","unstructured":"Suzu S, Yokota H, Yamada M, Yanai N, Saito M, Takaku F (1989) Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res 49: 5913","journal-title":"Cancer Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1349-7006.1990.tb02510.x","volume":"81","author":"S Suzu","year":"1990","unstructured":"Suzu S, Yanai N, Saito M, Kawashoma T, Kasahara T, Saito M, Takaku F, Motoyoshi K (1990) Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor. Jpn J Cancer Res 81: 79","journal-title":"Jpn J Cancer Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1073\/pnas.83.14.5233","volume":"83","author":"JL Urban","year":"1986","unstructured":"Urban JL, Shepard HM, Rothstein JL, Surgarman BJ (1986) Tumor necrosis factor. A potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 83: 5233","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.137.7.2281","volume":"137","author":"MK Warren","year":"1986","unstructured":"Warren MK, Ralph P (1986) Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony-stimulating activity. J Immunol 137: 2281","journal-title":"J Immunol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0090-1229(87)90036-5","volume":"45","author":"S Welt","year":"1987","unstructured":"Welt S, Carwell EA, Vogel CW, Oetgen HF, Old L (1987) Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells. Clin Immunol Immunopathol 45: 214","journal-title":"Clin Immunol Immunopathol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00199221","volume":"19","author":"E Yanagawa","year":"1985","unstructured":"Yanagawa E, Uchida A, Moore M, Mickshe M (1985) Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patients. Cancer Immunol Immunother 19: 163","journal-title":"Cancer Immunol Immunother"}],"container-title":["Cancer Immunology Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01516935\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01516935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01516935\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01516935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:14:58Z","timestamp":1683072898000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01516935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF01516935"],"URL":"https:\/\/doi.org\/10.1007\/bf01516935","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}